Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2025-10-10 00:00:00 ET · period of report 2025-10-08 · accession 0001522780-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-10 | 2025-10-08 | STOK | Kaye Edward M. MD | Dir | S - Sale+OE | $30.00 | -25.0K | 49.1K | -34% | -$750.0K |
| D | 2025-10-10 | 2025-10-08 | STOK | Kaye Edward M. MD | Dir | M - OptEx | $0.6 | +25.0K | 74.1K | +51% | +$15.0K |
| D | 2025-10-10 | 2025-10-08 | STOK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | -25.0K | 542.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-08 | S | D | 25,000 | $30.00 | 49,124 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-08 | M | A | 25,000 | $0.6 | 74,124 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-10-08 | M | D | 25,000 | $0.00 | 542,801 | D | $0.6 · — to 2028-04-02 | 25,000 Common Stock | (F2) The option vested as to 1/4th of the total award on October 17, 2018, with another 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Accordingly, this stock option is now fully vested. |